semaglutide gout GLP-1s may increase risk of osteoporosis and gout, new research finds Tirzepatide and change in uric

That said, both medications are FDA-approved, effective treatments for obesity and type 2 diabetes and the ideal choice depends on individual patient factors

As weve seen in our own program over the last year, the benefits of these medications far outweigh the risks which is why we understand and support patients who feel like they dont want to quit the medications cold turkey. Keep in mind that the FDA has approved the medications for indefinite use

Unfortunately, these meds aren't magical cures they also require lifestyle changes

In animal studies, semaglutide and tirzepatide caused thyroid tumors in rodents

Symptoms include severe abdominal pain that may radiate to the back, with or without vomiting

The 1.0 mg dose kept most of the 2.4 mg weight effect in the STEP 2 comparison, and 0.5 mg has years of use behind it